Alprenolol Hydrochloride is a non-selective beta-blocker indicated for the clinical management of hypertension, edema, ventricular tachycardia, and atrial fibrillation. This category contains the active… Read more





Alprenolol Hydrochloride is a non-selective beta-blocker indicated for the clinical management of hypertension, edema, ventricular tachycardia, and atrial fibrillation. This category contains the active pharmaceutical ingredient alongside its pharmacopeial and non-pharmacopeial impurities, which are essential for rigorous impurity profiling, method validation, and quality control. Laboratories utilize these high-quality reference standards to accurately identify and quantify degradation products and synthetic by-products, ensuring regulatory compliance throughout the manufacturing process. Additionally, stable isotope labelled versions of Alprenolol Hydrochloride are available to serve as reliable internal standards for mass spectrometry-based assays, supporting precise pharmacokinetic studies and metabolic pathway investigations. By providing access to these critical materials, analytical teams can maintain the highest standards of safety and efficacy testing for this beta-adrenergic antagonist.